Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Glucose-induced metabolic memory in Schwann cells: prevention by PPAR agonists.

Kim ES, Isoda F, Kurland I, Mobbs CV.

Endocrinology. 2013 Sep;154(9):3054-66. doi: 10.1210/en.2013-1097. Epub 2013 May 24.

2.

Modulation Effect of Peroxisome Proliferator-Activated Receptor Agonists on Lipid Droplet Proteins in Liver.

Zhu YX, Zhang ML, Zhong Y, Wang C, Jia WP.

J Diabetes Res. 2016;2016:8315454. doi: 10.1155/2016/8315454. Epub 2015 Dec 7.

3.

Therapeutic effects of fenofibrate on diabetic peripheral neuropathy by improving endothelial and neural survival in db/db mice.

Cho YR, Lim JH, Kim MY, Kim TW, Hong BY, Kim YS, Chang YS, Kim HW, Park CW.

PLoS One. 2014 Jan 2;9(1):e83204. doi: 10.1371/journal.pone.0083204. eCollection 2014.

4.

Effects of PPARs agonists on cardiac metabolism in littermate and cardiomyocyte-specific PPAR-γ-knockout (CM-PGKO) mice.

Barbieri M, Di Filippo C, Esposito A, Marfella R, Rizzo MR, D'Amico M, Ferraraccio F, Di Ronza C, Duan SZ, Mortensen RM, Rossi F, Paolisso G.

PLoS One. 2012;7(4):e35999. doi: 10.1371/journal.pone.0035999. Epub 2012 Apr 26.

5.

Improved insulin sensitivity after treatment with PPARγ and PPARα ligands is mediated by genetically modulated transcripts.

Rasouli N, Kern PA, Elbein SC, Sharma NK, Das SK.

Pharmacogenet Genomics. 2012 Jul;22(7):484-97. doi: 10.1097/FPC.0b013e328352a72e.

6.

Astragalus polysaccharides repress myocardial lipotoxicity in a PPARalpha-dependent manner in vitro and in vivo in mice.

Chen W, Lai Y, Wang L, Xia Y, Chen W, Zhao X, Yu M, Li Y, Zhang Y, Ye H.

J Diabetes Complications. 2015 Mar;29(2):164-75. doi: 10.1016/j.jdiacomp.2014.11.007. Epub 2014 Nov 25.

PMID:
25499591
7.

Structurally diverse peroxisome proliferator-activated receptor agonists induce apoptosis in human uro-epithelial cells by a receptor-independent mechanism involving store-operated calcium channels.

Chopra B, Georgopoulos NT, Nicholl A, Hinley J, Oleksiewicz MB, Southgate J.

Cell Prolif. 2009 Oct;42(5):688-700. doi: 10.1111/j.1365-2184.2009.00628.x. Epub 2009 Jul 10.

PMID:
19614673
8.

The roles of peroxisome proliferator-activated receptors in the metabolic syndrome.

Mansour M.

Prog Mol Biol Transl Sci. 2014;121:217-66. doi: 10.1016/B978-0-12-800101-1.00007-7. Review.

PMID:
24373239
9.

Fenofibrate simultaneously induces hepatic fatty acid oxidation, synthesis, and elongation in mice.

Oosterveer MH, Grefhorst A, van Dijk TH, Havinga R, Staels B, Kuipers F, Groen AK, Reijngoud DJ.

J Biol Chem. 2009 Dec 4;284(49):34036-44. doi: 10.1074/jbc.M109.051052. Epub 2009 Oct 2.

10.

Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?

Tenenbaum A, Fisman EZ.

Cardiovasc Diabetol. 2012 Nov 14;11:140. doi: 10.1186/1475-2840-11-140. Review.

11.

Reactivation of peroxisome proliferator-activated receptor alpha in spontaneously hypertensive rat: age-associated paradoxical effect on the heart.

Purushothaman S, Sathik MM, Nair RR.

J Cardiovasc Pharmacol. 2011 Sep;58(3):254-62. doi: 10.1097/FJC.0b013e31822368d7.

PMID:
21654328
12.

Fenofibrate reduces systemic inflammation markers independent of its effects on lipid and glucose metabolism in patients with the metabolic syndrome.

Belfort R, Berria R, Cornell J, Cusi K.

J Clin Endocrinol Metab. 2010 Feb;95(2):829-36. doi: 10.1210/jc.2009-1487. Epub 2010 Jan 8.

13.
14.

Regulation of fatty acid oxidation in mouse cumulus-oocyte complexes during maturation and modulation by PPAR agonists.

Dunning KR, Anastasi MR, Zhang VJ, Russell DL, Robker RL.

PLoS One. 2014 Feb 5;9(2):e87327. doi: 10.1371/journal.pone.0087327. eCollection 2014.

15.

Untargeted metabolomic profiling as an evaluative tool of fenofibrate-induced toxicology in Fischer 344 male rats.

Ohta T, Masutomi N, Tsutsui N, Sakairi T, Mitchell M, Milburn MV, Ryals JA, Beebe KD, Guo L.

Toxicol Pathol. 2009 Jun;37(4):521-35. doi: 10.1177/0192623309336152.

PMID:
19458390
16.

High-fat diet-induced renal cell apoptosis and oxidative stress in spontaneously hypertensive rat are ameliorated by fenofibrate through the PPARα-FoxO3a-PGC-1α pathway.

Chung HW, Lim JH, Kim MY, Shin SJ, Chung S, Choi BS, Kim HW, Kim YS, Park CW, Chang YS.

Nephrol Dial Transplant. 2012 Jun;27(6):2213-25. doi: 10.1093/ndt/gfr613. Epub 2011 Nov 9.

PMID:
22076434
17.

Berberine regulates peroxisome proliferator-activated receptors and positive transcription elongation factor b expression in diabetic adipocytes.

Zhou J, Zhou S.

Eur J Pharmacol. 2010 Dec 15;649(1-3):390-7. doi: 10.1016/j.ejphar.2010.09.030. Epub 2010 Sep 21.

PMID:
20868663
18.

Fenofibrate improves renal lipotoxicity through activation of AMPK-PGC-1α in db/db mice.

Hong YA, Lim JH, Kim MY, Kim TW, Kim Y, Yang KS, Park HS, Choi SR, Chung S, Kim HW, Kim HW, Choi BS, Chang YS, Park CW.

PLoS One. 2014 May 6;9(5):e96147. doi: 10.1371/journal.pone.0096147. eCollection 2014. Erratum in: PLoS One. 2014;9(8):e105921.

19.
20.

Supplemental Content

Support Center